New diabetes clinical trial: SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Published on: March 23, 2023 at 09:30PM
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: SAL067; Drug: Alogliptin; Drug: Placebo
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Completed
https://ift.tt/EkNtWyj
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: SAL067; Drug: Alogliptin; Drug: Placebo
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Completed
https://ift.tt/EkNtWyj
Comments
Post a Comment